Tuchendler Dominika, Bolanowski Marek
Kliniczny Oddzial Endokrynologii, Szpital Wojskowy, Wrocław.
Endokrynol Pol. 2009 Nov-Dec;60(6):470-5.
Hormonal dysfunction of thyroid gland manifests, among other, in bone tissue disorders. The evaluation of changes in bone is possible not only by using the classical markers of bone turnover. Very interesting chemical compounds are osteoprotegerin and vitamin D; their serum concentration among patients with thyroid disorders can show the range of changes in bone metabolism. Osteoprotegerin possess an ability of reduction of bone resorption. Vitamin D has several "nonclassical" mechanisms of action, also the possibility of interaction with endogenous thyroid hormones. The aim of this study is to review the current literature concerning the role of osteoprotegerin and vitamin D in thyroid pathology.
甲状腺的激素功能障碍在其他方面表现为骨组织紊乱。不仅可以通过使用经典的骨转换标志物来评估骨骼的变化。骨保护素和维生素D是非常有趣的化合物;甲状腺疾病患者血清中它们的浓度可以显示骨代谢变化的范围。骨保护素具有降低骨吸收的能力。维生素D有几种“非经典”作用机制,也有与内源性甲状腺激素相互作用的可能性。本研究的目的是综述目前关于骨保护素和维生素D在甲状腺病理学中作用的文献。